# A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD

> **NCT07116889** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Generate Biomedicines** · enrollment: 156 (estimated)

## Conditions studied

- Asthma
- COPD (Chronic Obstructive Pulmonary Disease)

## Interventions

- **BIOLOGICAL:** GB-0895 (SC)
- **BIOLOGICAL:** GB-0895 (SC)
- **DRUG:** Placebo (SC)
- **DRUG:** Placebo (SC)

## Key facts

- **NCT ID:** NCT07116889
- **Lead sponsor:** Generate Biomedicines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-12-12
- **Primary completion:** 2027-05
- **Final completion:** 2027-05
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2025-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07116889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07116889, "A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07116889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*